Kilitch Drugs Rights Issue dates 23 July – 21 August 2025.
Incorporated in 1978, Kilitch Drugs (India) (KDL) is a diversified pharmaceutical company engaged in the development, manufacturing, marketing, and export of a wide range of pharmaceutical formulations. Its product portfolio spans solid, liquid, and parenteral dosage forms. The company has a robust global footprint, with exports to Africa, Asia, the CIS, and Latin America, and a strategic focus on Africa, where it operates a cephalosporin manufacturing facility in Ethiopia, producing tablets, capsules, injectables, and dry powders.
Kilitch’s offerings are segmented into key categories: Parenterals and Nasal (liquid ampoules, vials, dry powder injectables for gastroenterology, anti-malarial, diagnostic, and veterinary use); Oral and Nutritional Products (antibiotics, anti-diabetics, cardiovascular tablets and syrups); Effervescent powders and tablets; CE-certified medical devices like the topical C-Seal adhesive; and Cosmetics & Herbal products for skincare, diabetes, obesity, and more.
The company serves a diverse clientele, including Asian Paints, Mankind Pharma, Indoco Remedies, Fusion Health Care, Shalina, and Ava Care Health, reinforcing its position as a trusted pharmaceutical partner across multiple continents.
Promoters of Kilitch Drugs (India) – Mukund Mehta And Kilitch Company (Pharma) Limited
Table of Contents
Kilitch Drugs (India) Rights Issue Details
| Kilitch Drugs Rights Issue Date | 23 July – 21 August 2025 |
| Kilitch Drugs Rights Issue Price | INR 357 per share |
| Issue Size (in Shares) | 13,98,463 shares |
| Issue Size (in INR) | INR 49.93 crore |
| Issue Entitlement | 2 equity shares for every 23 equity shares held on the record date |
| Terms of Payment | Fully payable at the time of application |
| Kilitch Drugs Rights Issue Record Date | 15 July 2025 |
| Face Value | INR 10 per share |
| Listing On | BSE, NSE |
Kilitch Drugs Rights Issue Calculation
| Kilitch Drugs Rights Issue Price | INR 357 per share |
| Market Price on Rights Issue Approval | INR 421 per share |
| Dilution Factor (X) | 1.09 |
| Fair Value After Dilution at Prevailing Price | INR 415.88 per share |
Kilitch Drugs Financial Performance
| FY 2023 | FY 2024 | FY 2025 | |
| Revenue | 140 | 154 | 198 |
| Expenses | 122 | 130 | 167 |
| OPM (%) | 13.0 | 16.0 | 16.0 |
| Net Income | 8.0 | 14.0 | 25.0 |
| ROCE (%) | 10.0 | 13.0 | 17.0 |
Kilitch Drugs Rights Offer Objectives
The net proceeds from the offer are proposed to be used for
- Funding capital expenditure for the Greenfield Project at Pen, Maharashtra, India
- General corporate purposes
Kilitch Drugs Rights Offer Documents
- Kilitch Drugs Rights Issue Application Form
- Kilitch Drugs Letter of Offer
- Board Meeting Outcome
- Kilitch Drugs Draft Letter of Offer
- Rights Issue in 2024
Kilitch Drugs Rights Issue Dates
| Rights Issue Approval Date | 9 July 2025 |
| Rights Issue Record Date | 15 July 2025 |
| Credit of Rights Entitlement | 16 July 2025 |
| Rights Issue Opening Date | 23 July 2025 |
| Last Date for Market Renunciation | 18 August 2025 |
| Rights Issue Closing Date | 21 August 2025 |
| Finalization of Basis of Allotment | 25 August 2025 |
| Rights Allotment Date | 25 August 2025 |
| Credit Date | 26 August 2025 |
| Listing Date | 28 August 2025 |
Kilitch Drugs Rights Offer Registrar
MUFG INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park L.B.S. Marg,
Vikhroli West, Mumbai – 400 083, Maharashtra
Telephone: +91 810 811 4949
Email: [email protected]
Website: www.in.mpms.mufg.com
Kilitch Drugs Contact Details
KILITCH DRUGS (INDIA) LIMITED
37, Ujagar Industrial Estate, W. T. Patil Marg,
Deonar, Mumbai, Maharashtra, India, 400088
Phone: +022 61214100
Email: [email protected]
Website: www.kilitch.com
Kilitch Drugs Rights Offer FAQs
What is the Kilitch Drugs Rights Issue Price?
The issue price is INR 357 per share.
What is the Kilitch Drugs Rights Issue entitlement ratio?
The eligible shareholders are offered 2 equity shares for every 23 equity shares held on the record date.
What is the Kilitch Drugs Rights Issue Record Date?
The Record date is 15 July 2025.
How to Apply in the Kilitch Drugs Rights Offer?
The best way to apply in the Kilitch Drugs Rights Offer is through Internet banking ASBA. You can also apply online through your stockbroker using UPI. If you prefer to make paper applications, fill up an application form and deposit the same with your broker.